The Indian Journal of Pediatrics

, Volume 71, Issue 5, pp 433–435 | Cite as

Toxic shock syndrome

Clinical Brief


The authors present two children who had fever ≥38.9°C, diffuse rash, hypotension, deranged renal and hepatic functions, disseminated intravascular coagulation, altered sensorium and inflamed oral mucosa. They responded to fluids, inotropes, antibiotics and intravenous immunoglobulin (2 g/kg). Desquamation particularly of palms and soles and periungal region was noted 1 to 2 weeks after onset of illness. These features were consistent with the diagnosis of staphylococcal toxic shock syndrome (TSS). The cases highlight that TSS is very much with us and can mimic a variety of other diseases. Early recognition, and aggressive antimicrobial supportive and IVIG therapy cover can ensure complete recovery

Key words

Children Intravenous immunoglobulin Staphylococcus aureus Toxic shock syndrome 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Todd J, Fishaut M, Kapral F, Welch T. Toxic-shock syndrome associated with phage group I Staphylococci.Lancet 1978; 2: 1116–1118.PubMedCrossRefGoogle Scholar
  2. 2.
    Schrock CG. Disease alert. (Letter)JAMA 1980; 243(12): 1231.PubMedCrossRefGoogle Scholar
  3. 3.
    Silver MA, Simon GL. Toxic shock syndrome in a male postoperative patient.J Trauma 1981; 21: 650–651.PubMedCrossRefGoogle Scholar
  4. 4.
    Reingold AL, Hargrett NT, Dan BBet al. Nonmenstruating toxic shock syndrome: Review of 130 cases.Ann Intern Med 1982; 96: 871–874.PubMedGoogle Scholar
  5. 5.
    Wiesenthal AM, Todd JK. Toxic shock syndrome in children aged 10 years or less.Pediatrics 1984; 74: 112–117.PubMedGoogle Scholar
  6. 6.
    Greenman RL, Immerman RP. Toxic shock syndrome: what we have learned?Postgrad Med 1987; 81(4): 147–160.PubMedGoogle Scholar
  7. 7.
    Manders SM. Toxin-mediated streptococcal and staphylococcal disease.J Am Acad Dermatol 1998; 39(3): 383–398.PubMedCrossRefGoogle Scholar
  8. 8.
    Issa NC, Thompson RL. Staphylococcal toxic shock syndrome-suspicion and prevention are keys to control.Postgrad Med 2001; 110(4): 59–62.Google Scholar
  9. 9.
    Todd JK. Staphylococcal infections-Toxic shock syndrome. In Behrman RE, Kliegman RM and Jenson HB eds.Nelson Textbook of Pediatrics. 16th Edition, WB Saunders. 2000; 797–798.Google Scholar
  10. 10.
    Davis JP, Chesney PJ, Wand PJet al. Toxic-shock syndrome: epidepmiologic features, recurrence, risk factors, and prevention.N Engl J Med 1980; 303(25) : 1429–1435.PubMedCrossRefGoogle Scholar
  11. 11.
    Barry W, Hudgins L, Donta ST, Pesanti EL. Intravenous immunoglobulin therapy for toxic shock syndrome.JAMA 1992; 267: 3315–3316.PubMedCrossRefGoogle Scholar
  12. 12.
    Davis J, Vergeront J, and Chesney PJ. Possible host defense mechanisms in toxic shock syndrome.Ann Intern Med 1982; 96: 986–991.PubMedGoogle Scholar
  13. 13.
    Davies HD, Kirk V, Jadavji T, Kotzin BL. Simultaneous presentation of Kawasaki disease and toxic shock syndrome in an adolescent male.Pediatr Infect Dis J 1996; 15(12): 1136–1138.PubMedCrossRefGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 2004

Authors and Affiliations

  1. 1.Department of Pediatrics, Advanced Pediatrics CentrePostgraduate Institute of Medical Education and Research (PGIMER)ChandigarhIndia

Personalised recommendations